Gastrointestinal Oncologists focus on diagnosing and treating cancers of the digestive system, which includes the esophagus, stomach, liver, pancreas, intestines, and colorectal region. These cancers can often present with vague or nonspecific symptoms, making early diagnosis challenging. Gastrointestinal oncologists utilize advanced diagnostic tools, including imaging tests, endoscopies, biopsies, and blood tests, to accurately identify the presence and stage of cancer. Based on this information, they create personalized treatment plans that may involve a combination of surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments.
Their expertise in cancer treatment, gastrointestinal oncologists also focus on helping patients manage the physical and emotional challenges associated with their condition. Many of the digestive system cancers can affect a patient's ability to eat, digest, or absorb nutrients, so gastrointestinal oncologists work with nutritionists and pain management teams to improve quality of life. They are also integral in providing ongoing follow-up care to monitor for recurrence and manage any side effects from treatment. With their specialized knowledge and compassionate approach, gastrointestinal oncologists play a critical role in improving both survival outcomes and the overall well-being of patients facing gastrointestinal cancers. Their ability to provide comprehensive, patient-centered care is vital in helping patients navigate the complexities of gastrointestinal cancer treatment.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China